These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7350930)

  • 1. Bone marrow delta-aminolaevulinate synthase deficiency in a female with congenital sideroblastic anemia.
    Buchanan GR; Bottomley SS; Nitschke R
    Blood; 1980 Jan; 55(1):109-15. PubMed ID: 7350930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sideroblastic anemia showing unique response to pyridoxine.
    Murakami R; Takumi T; Gouji J; Nakamura H; Kondou M
    Am J Pediatr Hematol Oncol; 1991; 13(3):345-50. PubMed ID: 1793162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haem synthesis in sideroblastic anaemia.
    Konopka L; Hoffbrand AV
    Br J Haematol; 1979 May; 42(1):73-83. PubMed ID: 465361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acquired, vitamin B6-responsive, primary sideroblastic anemia, an enzyme deficiency in heme synthesis].
    Meier PJ; Giger U; Brändli O; Fehr J
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1533-5. PubMed ID: 7313623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxine-responsive primary acquired sideroblastic anaemia. In vitro and in vivo effects of vitamin B6 on decreased 5-aminolaevulinate synthase activity.
    Meier PJ; Fehr J; Meyer UA
    Scand J Haematol; 1982 Nov; 29(5):421-4. PubMed ID: 7156891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
    Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
    N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease.
    Aoki Y; Muranaka S; Nakabayashi K; Ueda Y
    J Clin Invest; 1979 Nov; 64(5):1196-203. PubMed ID: 500806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
    Bottomley SS; Healy HM; Brandenburg MA; May BK
    Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation of the erythroid-specific gamma-Aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia.
    Harigae H; Furuyama K; Kudo K; Hayashi N; Yamamoto M; Sassa S; Sasaki T
    Am J Hematol; 1999 Oct; 62(2):112-4. PubMed ID: 10577279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of a female with congenital sideroblastic anemia.
    Manabe Y; Seto S; Furusho K; Aoki Y
    Am J Hematol; 1982 Feb; 12(1):63-7. PubMed ID: 7039309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haema synthesis during pyridoxine therapy in two families with different types of hereditary sideroblastic anaemia.
    Pasanen AV; Salmi M; Tenhunen R; Vuopio P
    Ann Clin Res; 1982 Apr; 14(2):61-5. PubMed ID: 7149613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple enzymatic defects in mitochondria in hematological cells of patients with primary sideroblastic anemia.
    Aoki Y
    J Clin Invest; 1980 Jul; 66(1):43-9. PubMed ID: 6249845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sideroblastic anemia.
    Kushner JP; Cartwright GE
    Adv Intern Med; 1977; 22():229-49. PubMed ID: 320843
    [No Abstract]   [Full Text] [Related]  

  • 15. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
    Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
    Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-aminolevulinic acid synthetase activity in normal human bone marrow and in patients with idiopathic sideroblastic anemia.
    Bottomley SS; Tanaka M; Self J
    Enzyme; 1973; 16(1):138-45. PubMed ID: 4208577
    [No Abstract]   [Full Text] [Related]  

  • 17. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An infant case of sideroblastic anemia that responded to oral pyridoxine].
    Kudo K; Ito M; Horibe K; Iwase K; Kojima S
    Rinsho Ketsueki; 1999 Aug; 40(8):667-72. PubMed ID: 10496043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.
    Cotter PD; Baumann M; Bishop DF
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4028-32. PubMed ID: 1570328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of heme metabolism in normal and sideroblastic bone marrow cells in culture.
    Ibraham NG; Lutton JD; Hoffman R; Levere RD
    J Lab Clin Med; 1985 May; 105(5):593-600. PubMed ID: 3989352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.